R&D Evaluating methods targeting Protein-Protein Interactions Protein-protein interactions (PPIs) are becoming increasingly relevant in the pathology of many diseases, including cancer.
News MSD rumoured to be nearing $6bn play for Terns Pharma MSD's glut of pipeline-boosting deals in the build-up to a looming patent cliff is reported to be continuing with a $6bn bid to acquire Terns Pharma.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
